PHARMACOTHERAPY OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER ACROSS THE LIFE CYCLE
Gorde:
SPENCER, T., ET AL., PHARMACOTHERAPY OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER ACROSS THE LIFE CYCLE. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol. 35, no. 4 (1996), p. 409-432.
Erref.
52387
Kokapena:
SIIS SIIS Madrid R.598
Hitz-gakoak:
Enfermedades mentales, Fármacos, Hiperactividad, Trastornos de atención, Tratamiento médico
Enfermedades mentales, Fármacos, Hiperactividad, Trastornos de atención, Tratamiento médico
Antzeko izenburuak: PHARMACOTHERAPY OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER ACROSS THE LIFE CYCLE
- THE DEVELOPMENT OF SELECTIVE ATTENTION IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
- CURRENT PRACTICE IN THE MANAGEMENT OF ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY (ADHD)
- PHARMACODYNAMICS OF PEMOLINE IN ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
- AN AUDITABLE PROTOCOL FOR TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER.
- PSYCHOSTIMULANTS IN PRESCHOOL CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: CLINICAL EVIDENCE FROM A DEVELOPMENTAL DISORDERS INSTITUTION
- DESIPRAMINE TREATMENT OF CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND TIC DISORDER OR TOURETTE'S SYNDROME